Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.46 USD | -0.69% | +1.20% | -9.32% |
09/05 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
28/02 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.82B | - | - | - | - | - | |
115B | ||||||
106B | ||||||
21.96B | - | |||||
21.87B | - | |||||
19.21B |
- Stock Market
- Equities
- INBX Stock
- Charts Inhibrx, Inc.
- Sector Chart